Association of cimetidine and bone-marrow suppression in man

1 September 1979

journal article
case report
Published by Springer Nature in Digestive Diseases and Sciences

Vol. 24 (9) , 730-731
https://doi.org/10.1007/bf01314472

Abstract

A 29-year-old woman who was on steroids for Behçet's disease received intravenous cimetidine for severe gastrointestinal bleeding. A bone-marrow examination performed a few days prior to cimetidine treatment showed a normally active marrow. On the fifth day of cimetidine therapy, agranulocytosis (800/ml) and a very low platelet count (40,000/ml) were observed; bone-marrow failure was documented both by biopsy and aspiration. No other drug known to be myelotoxic was given. This severe hematologic side effect of cimetidine resolved within 10 days after discontinuation of the drug.

Keywords

This publication has 14 references indexed in Scilit:

Cimetidine for gastric and duodenal ulcer?
The American Journal of Medicine, 1978
Cimetidine
New England Journal of Medicine, 1978
MARROW SUPPRESSION AND INTRAVENOUS CIMETIDINE
The Lancet, 1978
CIMETIDINE AND BONE-MARROW TOXICITY
The Lancet, 1978
LEUCOPENIA WITH CIMETIDINE
The Lancet, 1977
CIMETIDINE AND BONE-MARROW TOXICITY
The Lancet, 1977
AGRANULOCYTOSIS FOUR MONTHS AFTER CIMETIDINE THERAPY
The Lancet, 1977
Oral ulceration and Behcet's syndrome.
Gut, 1977
Cimetidine Therapy in a Patient with Metiamide-Induced Agranulocytosis
New England Journal of Medicine, 1977
REVERSAL OF METIAMIDE-INDUCED AGRANULOCYTOSIS DURING TREATMENT WITH CIMETIDINE
The Lancet, 1975